Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP prolyl isomerase 4 pseudogene 2 (FKBP4P2) is a non-functional genomic sequence related to the FKBP4 gene, which encodes FK506-binding protein 4, a member of the immunophilin family with peptidyl-prolyl isomerase activity[4][5]. FKBP4P2 itself does not produce a functional protein and is not associated with receptor, enzyme, transporter, or other molecular target activity relevant to therapeutics or biology[4][5]. It is catalogued in genome annotation resources as a pseudogene found on chromosome 9 (chr9:39631046-39632416)[4]. There is no evidence that FKBP4P2 serves as a drug target, molecular biomarker, or disease-related gene. In summary, FKBP4P2 is not a therapeutic target and is correctly classified as a pseudogene. The actual functional protein in this family is FKBP4 (FK506-binding protein 4), but FKBP4P2 does not encode this protein and does not serve as a target for drugs or disease research[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP prolyl isomerase 4 pseudogene 2 (FKBP4P2).